BPH is an enlarged prostate. The prostate goes through two main growth cycles during a man?s life. The first occurs early in puberty, when the prostate doubles in size. The second phase of growth starts around age 25 and goes on for most of the rest of a man's life. BPH most often occurs during this second growth phase.
This report aims to provide a comprehensive presentation of the global market for Benign Prostatic Hyperplasia (BPH) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Benign Prostatic Hyperplasia (BPH) Drugs. This report contains market size and forecasts of Benign Prostatic Hyperplasia (BPH) Drugs in global, including the following market information:
- Global Benign Prostatic Hyperplasia (BPH) Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global Benign Prostatic Hyperplasia (BPH) Drugs Market Sales, 2018-2023, 2024-2029, (M Units)
Global top five Benign Prostatic Hyperplasia (BPH) Drugs companies in 2022 (%)
The global Benign Prostatic Hyperplasia (BPH) Drugs market was valued at US$ 3425.9 million in 2022 and is projected to reach US$ 4258.9 million by 2029, at a CAGR of 3.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest consumption place, with a consumption market share nearly 38% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 27.6%. Market competition is intense. Eli Lilly, GlaxoSmithKline, Astellas Pharma, Sanofi, Pfizer, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
We surveyed the Benign Prostatic Hyperplasia (BPH) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Benign Prostatic Hyperplasia (BPH) Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Benign Prostatic Hyperplasia (BPH) Drugs Market Segment Percentages, by Type, 2022 (%)
- Alpha-Blocker
- Phosphodiesterase Type-5 Inhibitors
- Others
Global Benign Prostatic Hyperplasia (BPH) Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Benign Prostatic Hyperplasia (BPH) Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Drugstores
- Others
Global Benign Prostatic Hyperplasia (BPH) Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Benign Prostatic Hyperplasia (BPH) Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Benign Prostatic Hyperplasia (BPH) Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Benign Prostatic Hyperplasia (BPH) Drugs revenues share in global market, 2022 (%)
- Key companies Benign Prostatic Hyperplasia (BPH) Drugs sales in global market, 2018-2023 (Estimated), (M Units)
- Key companies Benign Prostatic Hyperplasia (BPH) Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Eli Lilly
- GlaxoSmithKline
- Astellas Pharma
- Sanofi
- Pfizer
- Abbott
- Allergan
- TEVA
- Mylan
- Novartis
- Merck
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Benign Prostatic Hyperplasia (BPH) Drugs, market overview.
- Chapter 2: Global Benign Prostatic Hyperplasia (BPH) Drugs market size in revenue and volume.
- Chapter 3: Detailed analysis of Benign Prostatic Hyperplasia (BPH) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Benign Prostatic Hyperplasia (BPH) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Benign Prostatic Hyperplasia (BPH) Drugs capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Benign Prostatic Hyperplasia (BPH) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Benign Prostatic Hyperplasia (BPH) Drugs Overall Market Size
2.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size: 2022 VS 2029
2.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Benign Prostatic Hyperplasia (BPH) Drugs Players in Global Market
3.2 Top Global Benign Prostatic Hyperplasia (BPH) Drugs Companies Ranked by Revenue
3.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Companies
3.4 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales by Companies
3.5 Global Benign Prostatic Hyperplasia (BPH) Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Benign Prostatic Hyperplasia (BPH) Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Benign Prostatic Hyperplasia (BPH) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Benign Prostatic Hyperplasia (BPH) Drugs Players in Global Market
3.8.1 List of Global Tier 1 Benign Prostatic Hyperplasia (BPH) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Benign Prostatic Hyperplasia (BPH) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size Markets, 2022 & 2029
4.1.2 Alpha-Blocker
4.1.3 Phosphodiesterase Type-5 Inhibitors
4.1.4 Others
4.2 By Type - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue & Forecasts
4.2.1 By Type - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue, 2018-2023
4.2.2 By Type - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue, 2024-2029
4.2.3 By Type - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales & Forecasts
4.3.1 By Type - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales, 2018-2023
4.3.2 By Type - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales, 2024-2029
4.3.3 By Type - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Benign Prostatic Hyperplasia (BPH) Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue & Forecasts
5.2.1 By Application - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue, 2018-2023
5.2.2 By Application - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue, 2024-2029
5.2.3 By Application - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales & Forecasts
5.3.1 By Application - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales, 2018-2023
5.3.2 By Application - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales, 2024-2029
5.3.3 By Application - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Benign Prostatic Hyperplasia (BPH) Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2022 & 2029
6.2 By Region - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue & Forecasts
6.2.1 By Region - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue, 2018-2023
6.2.2 By Region - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue, 2024-2029
6.2.3 By Region - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales & Forecasts
6.3.1 By Region - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales, 2018-2023
6.3.2 By Region - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales, 2024-2029
6.3.3 By Region - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Benign Prostatic Hyperplasia (BPH) Drugs Revenue, 2018-2029
6.4.2 By Country - North America Benign Prostatic Hyperplasia (BPH) Drugs Sales, 2018-2029
6.4.3 US Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.4.4 Canada Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.4.5 Mexico Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales, 2018-2029
6.5.3 Germany Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.5.4 France Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.5.5 U.K. Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.5.6 Italy Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.5.7 Russia Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.5.9 Benelux Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales, 2018-2029
6.6.3 China Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.6.4 Japan Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.6.5 South Korea Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.6.7 India Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Benign Prostatic Hyperplasia (BPH) Drugs Revenue, 2018-2029
6.7.2 By Country - South America Benign Prostatic Hyperplasia (BPH) Drugs Sales, 2018-2029
6.7.3 Brazil Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.7.4 Argentina Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Sales, 2018-2029
6.8.3 Turkey Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.8.4 Israel Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
6.8.6 UAE Benign Prostatic Hyperplasia (BPH) Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Major Product Offerings
7.1.4 Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Eli Lilly Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Sales and Revenue in Global (2018-2023)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Astellas Pharma
7.3.1 Astellas Pharma Company Summary
7.3.2 Astellas Pharma Business Overview
7.3.3 Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Major Product Offerings
7.3.4 Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Astellas Pharma Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Major Product Offerings
7.4.4 Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Benign Prostatic Hyperplasia (BPH) Drugs Major Product Offerings
7.5.4 Pfizer Benign Prostatic Hyperplasia (BPH) Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Abbott
7.6.1 Abbott Company Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Benign Prostatic Hyperplasia (BPH) Drugs Major Product Offerings
7.6.4 Abbott Benign Prostatic Hyperplasia (BPH) Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Abbott Key News & Latest Developments
7.7 Allergan
7.7.1 Allergan Company Summary
7.7.2 Allergan Business Overview
7.7.3 Allergan Benign Prostatic Hyperplasia (BPH) Drugs Major Product Offerings
7.7.4 Allergan Benign Prostatic Hyperplasia (BPH) Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Allergan Key News & Latest Developments
7.8 TEVA
7.8.1 TEVA Company Summary
7.8.2 TEVA Business Overview
7.8.3 TEVA Benign Prostatic Hyperplasia (BPH) Drugs Major Product Offerings
7.8.4 TEVA Benign Prostatic Hyperplasia (BPH) Drugs Sales and Revenue in Global (2018-2023)
7.8.5 TEVA Key News & Latest Developments
7.9 Mylan
7.9.1 Mylan Company Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan Benign Prostatic Hyperplasia (BPH) Drugs Major Product Offerings
7.9.4 Mylan Benign Prostatic Hyperplasia (BPH) Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Mylan Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Benign Prostatic Hyperplasia (BPH) Drugs Major Product Offerings
7.10.4 Novartis Benign Prostatic Hyperplasia (BPH) Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Novartis Key News & Latest Developments
7.11 Merck
7.11.1 Merck Company Summary
7.11.2 Merck Benign Prostatic Hyperplasia (BPH) Drugs Business Overview
7.11.3 Merck Benign Prostatic Hyperplasia (BPH) Drugs Major Product Offerings
7.11.4 Merck Benign Prostatic Hyperplasia (BPH) Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Merck Key News & Latest Developments
8 Global Benign Prostatic Hyperplasia (BPH) Drugs Production Capacity, Analysis
8.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Production Capacity, 2018-2029
8.2 Benign Prostatic Hyperplasia (BPH) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Benign Prostatic Hyperplasia (BPH) Drugs Supply Chain Analysis
10.1 Benign Prostatic Hyperplasia (BPH) Drugs Industry Value Chain
10.2 Benign Prostatic Hyperplasia (BPH) Drugs Upstream Market
10.3 Benign Prostatic Hyperplasia (BPH) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Benign Prostatic Hyperplasia (BPH) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Benign Prostatic Hyperplasia (BPH) Drugs in Global Market
Table 2. Top Benign Prostatic Hyperplasia (BPH) Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Benign Prostatic Hyperplasia (BPH) Drugs Sales by Companies, (M Units), 2018-2023
Table 6. Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Benign Prostatic Hyperplasia (BPH) Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Benign Prostatic Hyperplasia (BPH) Drugs Product Type
Table 9. List of Global Tier 1 Benign Prostatic Hyperplasia (BPH) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Benign Prostatic Hyperplasia (BPH) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (M Units), 2018-2023
Table 15. By Type - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (M Units), 2024-2029
Table 16. By Application ? Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (M Units), 2018-2023
Table 20. By Application - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (M Units), 2024-2029
Table 21. By Region ? Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (M Units), 2018-2023
Table 25. By Region - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (M Units), 2024-2029
Table 26. By Country - North America Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Benign Prostatic Hyperplasia (BPH) Drugs Sales, (M Units), 2018-2023
Table 29. By Country - North America Benign Prostatic Hyperplasia (BPH) Drugs Sales, (M Units), 2024-2029
Table 30. By Country - Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales, (M Units), 2018-2023
Table 33. By Country - Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales, (M Units), 2024-2029
Table 34. By Region - Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales, (M Units), 2018-2023
Table 37. By Region - Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales, (M Units), 2024-2029
Table 38. By Country - South America Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Benign Prostatic Hyperplasia (BPH) Drugs Sales, (M Units), 2018-2023
Table 41. By Country - South America Benign Prostatic Hyperplasia (BPH) Drugs Sales, (M Units), 2024-2029
Table 42. By Country - Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Sales, (M Units), 2018-2023
Table 45. By Country - Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Sales, (M Units), 2024-2029
Table 46. Eli Lilly Company Summary
Table 47. Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Product Offerings
Table 48. Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Eli Lilly Key News & Latest Developments
Table 50. GlaxoSmithKline Company Summary
Table 51. GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Product Offerings
Table 52. GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. GlaxoSmithKline Key News & Latest Developments
Table 54. Astellas Pharma Company Summary
Table 55. Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Product Offerings
Table 56. Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Astellas Pharma Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Product Offerings
Table 60. Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Benign Prostatic Hyperplasia (BPH) Drugs Product Offerings
Table 64. Pfizer Benign Prostatic Hyperplasia (BPH) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Pfizer Key News & Latest Developments
Table 66. Abbott Company Summary
Table 67. Abbott Benign Prostatic Hyperplasia (BPH) Drugs Product Offerings
Table 68. Abbott Benign Prostatic Hyperplasia (BPH) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Abbott Key News & Latest Developments
Table 70. Allergan Company Summary
Table 71. Allergan Benign Prostatic Hyperplasia (BPH) Drugs Product Offerings
Table 72. Allergan Benign Prostatic Hyperplasia (BPH) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Allergan Key News & Latest Developments
Table 74. TEVA Company Summary
Table 75. TEVA Benign Prostatic Hyperplasia (BPH) Drugs Product Offerings
Table 76. TEVA Benign Prostatic Hyperplasia (BPH) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. TEVA Key News & Latest Developments
Table 78. Mylan Company Summary
Table 79. Mylan Benign Prostatic Hyperplasia (BPH) Drugs Product Offerings
Table 80. Mylan Benign Prostatic Hyperplasia (BPH) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Mylan Key News & Latest Developments
Table 82. Novartis Company Summary
Table 83. Novartis Benign Prostatic Hyperplasia (BPH) Drugs Product Offerings
Table 84. Novartis Benign Prostatic Hyperplasia (BPH) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Novartis Key News & Latest Developments
Table 86. Merck Company Summary
Table 87. Merck Benign Prostatic Hyperplasia (BPH) Drugs Product Offerings
Table 88. Merck Benign Prostatic Hyperplasia (BPH) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Merck Key News & Latest Developments
Table 90. Benign Prostatic Hyperplasia (BPH) Drugs Production Capacity (M Units) of Key Manufacturers in Global Market, 2021-2023 (M Units)
Table 91. Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Benign Prostatic Hyperplasia (BPH) Drugs Production by Region, 2018-2023 (M Units)
Table 93. Global Benign Prostatic Hyperplasia (BPH) Drugs Production by Region, 2024-2029 (M Units)
Table 94. Benign Prostatic Hyperplasia (BPH) Drugs Market Opportunities & Trends in Global Market
Table 95. Benign Prostatic Hyperplasia (BPH) Drugs Market Drivers in Global Market
Table 96. Benign Prostatic Hyperplasia (BPH) Drugs Market Restraints in Global Market
Table 97. Benign Prostatic Hyperplasia (BPH) Drugs Raw Materials
Table 98. Benign Prostatic Hyperplasia (BPH) Drugs Raw Materials Suppliers in Global Market
Table 99. Typical Benign Prostatic Hyperplasia (BPH) Drugs Downstream
Table 100. Benign Prostatic Hyperplasia (BPH) Drugs Downstream Clients in Global Market
Table 101. Benign Prostatic Hyperplasia (BPH) Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Benign Prostatic Hyperplasia (BPH) Drugs Segment by Type in 2022
Figure 2. Benign Prostatic Hyperplasia (BPH) Drugs Segment by Application in 2022
Figure 3. Global Benign Prostatic Hyperplasia (BPH) Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Benign Prostatic Hyperplasia (BPH) Drugs Sales in Global Market: 2018-2029 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Benign Prostatic Hyperplasia (BPH) Drugs Revenue in 2022
Figure 9. By Type - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Benign Prostatic Hyperplasia (BPH) Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Benign Prostatic Hyperplasia (BPH) Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share, 2018-2029
Figure 23. US Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share, 2018-2029
Figure 28. Germany Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share, 2018-2029
Figure 37. China Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Benign Prostatic Hyperplasia (BPH) Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Benign Prostatic Hyperplasia (BPH) Drugs Production Capacity (M Units), 2018-2029
Figure 53. The Percentage of Production Benign Prostatic Hyperplasia (BPH) Drugs by Region, 2022 VS 2029
Figure 54. Benign Prostatic Hyperplasia (BPH) Drugs Industry Value Chain
Figure 55. Marketing Channels
